|
V.S. Nikiforov
Possibilities of using trimetazidine in comorbid cardiovascular pathology and metabolic disorders
|
№13 / 2022
|
|
E.I. Vereshchagin, E.V. Svechnikova, N.O. Artemyeva
Modern possibilities for correcting the uric acid level and eliminating skin manifestations of gout
|
№13 / 2022
|
|
M.A. Morzhanaeva (1), E.V. Svechnikova (1, 2), E.V. Shchepkina (3), A.I. Kuznetsov (4)
Application of the diabetes screening questionnaire in patients with psoriasis
|
№4 / 2022
|
|
M.A. Morzhanaeva (1), E.V. Shchepkina (2)
Analysis of anxiety-depressive states of patients with psoriasis and diabetes mellitus
|
№8 / 2021
|
|
A.F. Subkhankulova (1), S.F. Subkhankulova (2)
Women’s health at an elegant age: the possibilities of menopausal hormone therapy
|
№6 / 2021
|
|
N.S. Alekseeva (1), E.V. Beloborodova (2)
The effectiveness of therapeutic measures in metabolic syndrome and vitamin d deficiency
|
№4 / 2019
|
|
S.A. Bulgakov
ESSENTIAL PHOSPHOLIPIDS IN THE TREATMENT OF HEPATIC DISORDERS
|
№s3 / 2018
|
|
A.F. Verbovoy (1), I.A. Tsanava (1), N.I. Verbovaya (1), R.A. Galkin (1), I.V. Madyanov (2)
POLYMORBIDITY AND MODERN MEDICINE
|
№16 / 2017
|
|
M.E. Statsenko, S.V. Turkina, I.A. Tyshchenko, S.V. Fabritskaya, L.V. Poletaeva
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
|
№6 / 2017
|
|
L.A. Sharonova, A.F. Verbovoy, I.A. Tsanava
STATE OF CARDIOVASCULAR SYSTEM IN METABOLIC SYNDROME
|
№5 / 2017
|
|
A.F. Verbovoy, L.A. Sharonova, A.V. Pashentseva, I.A. Tsanava
INSULIN RESISTANCE SYNDROME IN THE CLINIC OF INTERNAL DISEASES
|
№5 / 2017
|
|
E.N. Shirokova
NONALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK (LITERATURE REVIEW)
|
№2 / 2017
|
Русский
